XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes
- 17 June 2013
- journal article
- review article
- Published by Wiley in Hematological Oncology
- Vol. 31 (S1), 69-75
- https://doi.org/10.1002/hon.2070
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD studyBlood, 2012
- The Ratio of FOXP3+ Regulatory T Cells to Granzyme B+ Cytotoxic T/NK Cells Predicts Prognosis in Classical Hodgkin Lymphoma and Is Independent of bcl-2 and MAL ExpressionAmerican Journal of Clinical Pathology, 2007
- Standard CHOP-21 as first line therapy for elderly patients with Hodgkin's lymphomaLeukemia & Lymphoma, 2007
- Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study GroupAnnals of Oncology, 2006
- Independent prognostic effect of co-morbidity in lymphoma patients: Results of the population-based Eindhoven Cancer RegistryEuropean Journal of Cancer, 2005
- A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)Annals of Oncology, 2005
- Hodgkin's Disease in the Elderly: Improved Treatment Outcome With a Doxorubicin-Containing RegimenJournal of Clinical Oncology, 2002
- Patients above Sixty Years Lymphoma Treated with a New Strategy of Age with Hodgkin'sActa Oncologica, 2002
- Long-term survival in Hodgkin's disease patients: a comparison of relative survival in patients in trials and those recorded in population-based cancer registriesEuropean Journal of Cancer, 2000
- A Prognostic Score for Advanced Hodgkin's DiseaseThe New England Journal of Medicine, 1998